Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy

NCT03917719 is registered in ClinicalTrials.gov with Catabasis Pharmaceuticals as lead sponsor.

NCT NCT03917719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
Lead sponsor
Catabasis Pharmaceuticals
Phase
Phase 3
Overall status
Terminated
Start date
March 14, 2019
Completion date
October 26, 2020
Enrollment
130 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy